Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 129

1.

Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes.

Cannon CP, Blazing MA, Giugliano RP, McCagg A, White JA, Theroux P, Darius H, Lewis BS, Ophuis TO, Jukema JW, De Ferrari GM, Ruzyllo W, De Lucca P, Im K, Bohula EA, Reist C, Wiviott SD, Tershakovec AM, Musliner TA, Braunwald E, Califf RM; IMPROVE-IT Investigators.

N Engl J Med. 2015 Jun 18;372(25):2387-97. doi: 10.1056/NEJMoa1410489. Epub 2015 Jun 3.

2.

Endothelin receptor antagonists.

Clozel M, Maresta A, Humbert M.

Handb Exp Pharmacol. 2013;218:199-227. doi: 10.1007/978-3-642-38664-0_9. Review.

PMID:
24092342
3.

Bosentan fosters microvascular de-remodelling in systemic sclerosis.

Guiducci S, Bellando Randone S, Bruni C, Carnesecchi G, Maresta A, Iannone F, Lapadula G, Matucci Cerinic M.

Clin Rheumatol. 2012 Dec;31(12):1723-5. doi: 10.1007/s10067-012-2074-5. Epub 2012 Sep 29.

PMID:
23053682
4.

Impact of mitral regurgitation on the outcome of patients treated with CRT-D: data from the InSync ICD Italian Registry.

Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, Santini M, Padeletti L, Molon G, Botto G, de Santo T, Valsecchi S; InSync/InSync ICD Italian Registry Investigators.

Pacing Clin Electrophysiol. 2012 Feb;35(2):146-54. doi: 10.1111/j.1540-8159.2011.03280.x. Epub 2011 Dec 2.

PMID:
22132940
5.

Long-term outcome after sirolimus-eluting stents versus bare metal stents in patients with diabetes mellitus: a patient-level meta-analysis of randomized trials.

de Waha A, Dibra A, Kufner S, Baumgart D, Sabate M, Maresta A, Schömig A, Kastrati A.

Clin Res Cardiol. 2011 Jul;100(7):561-70. doi: 10.1007/s00392-010-0278-8. Epub 2011 Jan 8. Erratum in: Clin Res Cardiol. 2011 Sep;100(9):811-3.

PMID:
21221607
6.

A randomized double-blind comparison of biventricular versus left ventricular stimulation for cardiac resynchronization therapy: the Biventricular versus Left Univentricular Pacing with ICD Back-up in Heart Failure Patients (B-LEFT HF) trial.

Boriani G, Kranig W, Donal E, Calo L, Casella M, Delarche N, Lozano IF, Ansalone G, Biffi M, Boulogne E, Leclercq C; B-LEFT HF study group.

Am Heart J. 2010 Jun;159(6):1052-1058.e1. doi: 10.1016/j.ahj.2010.03.008.

PMID:
20569719
7.

Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry.

Balducelli M, Ortolani P, Marzaroli P, Piovaccari G, Menozzi A, Manari A, Sangiorgio P, Tarantino F, Rossi R, Maresta A, Tondi S, Passerini F, Guastaroba P, Grilli R, Marzocchi A.

Catheter Cardiovasc Interv. 2010 Feb 15;75(3):327-34. doi: 10.1002/ccd.22293.

PMID:
19937776
8.

Effectiveness of cardiac resynchronization therapy in heart failure patients with valvular heart disease: comparison with patients affected by ischaemic heart disease or dilated cardiomyopathy. The InSync/InSync ICD Italian Registry.

Boriani G, Gasparini M, Landolina M, Lunati M, Biffi M, Santini M, Padeletti L, Molon G, Botto G, De Santo T, Valsecchi S; InSync/InSync ICD Italian Registry Investigators.

Eur Heart J. 2009 Sep;30(18):2275-83. doi: 10.1093/eurheartj/ehp226. Epub 2009 Jun 10.

9.

Dual-chamber implantable cardioverter defibrillators reduce clinical adverse events related to atrial fibrillation when compared with single-chamber defibrillators: a subanalysis of the DATAS trial.

Ricci RP, Quesada A, Almendral J, Arribas F, Wolpert C, Adragao P, Zoni-Berisso M, Navarro X, DeSanto T, Grammatico A, Santini M; DATAS study Investigators.

Europace. 2009 May;11(5):587-93. doi: 10.1093/europace/eup072.

PMID:
19401341
10.

Are drug-eluting stents superior to bare-metal stents in patients with unprotected non-bifurcational left main disease? Insights from a multicentre registry.

Tamburino C, Di Salvo ME, Capodanno D, Marzocchi A, Sheiban I, Margheri M, Maresta A, Barlocco F, Sangiorgi G, Piovaccari G, Bartorelli A, Briguori C, Ardissino D, Di Pede F, Ramondo A, Inglese L, Petronio AS, Bolognese L, Benassi A, Palmieri C, Patti A, De Servi S.

Eur Heart J. 2009 May;30(10):1171-9. doi: 10.1093/eurheartj/ehp052. Epub 2009 Mar 10.

PMID:
19276194
11.

Administration of eptifibatide during transfer for primary PCI in patients with STEMI: effect on Pre-PCI TIMI flow and its correlation with pain-to-therapy time.

Aquilina M, Varani E, Balducelli M, Vecchi G, Frassineti V, Maresta A.

J Invasive Cardiol. 2009 Mar;21(3):115-20.

PMID:
19258642
12.

Percutaneous coronary interventions in octogenarians: Acute and 12 month results in a large single-centre experience.

Varani E, Aquilina M, Balducelli M, Vecchi G, Frassineti V, Maresta A.

Catheter Cardiovasc Interv. 2009 Mar 1;73(4):449-54. doi: 10.1002/ccd.21852.

PMID:
19229976
13.

Heart rate variability monitored by the implanted device predicts response to CRT and long-term clinical outcome in patients with advanced heart failure.

Landolina M, Gasparini M, Lunati M, Santini M, Rordorf R, Vincenti A, Diotallevi P, Montenero AS, Bonanno C, De Santo T, Valsecchi S, Padeletti L; InSync/InSync ICD Italian Registry Investigators.

Eur J Heart Fail. 2008 Nov;10(11):1073-9. doi: 10.1016/j.ejheart.2008.08.011. Epub 2008 Oct 1.

14.

Single or multivessel percutaneous coronary intervention in ST-elevation myocardial infarction patients.

Varani E, Balducelli M, Aquilina M, Vecchi G, Hussien MN, Frassineti V, Maresta A.

Catheter Cardiovasc Interv. 2008 Dec 1;72(7):927-33. doi: 10.1002/ccd.21722.

PMID:
18798239
15.

Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial.

Fox K, Ford I, Steg PG, Tendera M, Ferrari R; BEAUTIFUL Investigators.

Lancet. 2008 Sep 6;372(9641):807-16. doi: 10.1016/S0140-6736(08)61170-8. Epub 2008 Aug 29.

PMID:
18757088
17.

Comparison of effectiveness and safety of sirolimus-eluting stents versus bare-metal stents in patients with diabetes mellitus (from the Italian Multicenter Randomized DESSERT Study).

Maresta A, Varani E, Balducelli M, Varbella F, Lettieri C, Uguccioni L, Sangiorgio P, Zoccai GB; DESSERT Investigators.

Am J Cardiol. 2008 Jun 1;101(11):1560-6. doi: 10.1016/j.amjcard.2008.01.040. Epub 2008 Apr 11.

PMID:
18489933
18.

Dual-chamber defibrillators reduce clinically significant adverse events compared with single-chamber devices: results from the DATAS (Dual chamber and Atrial Tachyarrhythmias Adverse events Study) trial.

Almendral J, Arribas F, Wolpert C, Ricci R, Adragao P, Cobo E, Navarro X, Quesada A; DATAS Steering Committee; DATAS Writing Committee; DATAS Investigators.

Europace. 2008 May;10(5):528-35. doi: 10.1093/europace/eun072. Epub 2008 Apr 7.

PMID:
18390985
19.

Long-term outcomes with drug-eluting stents versus bare metal stents in the treatment of saphenous vein graft disease (results from the REgistro Regionale AngiopLastiche Emilia-Romagna registry).

Vignali L, Saia F, Manari A, Santarelli A, Rubboli A, Varani E, Piovaccari G, Menozzi A, Percoco G, Benassi A, Rusticali G, Marzaroli P, Guastaroba P, Grilli R, Maresta A, Marzocchi A.

Am J Cardiol. 2008 Apr 1;101(7):947-52. doi: 10.1016/j.amjcard.2007.11.055. Epub 2008 Feb 6.

PMID:
18359313
20.

Persistent atrial fibrillation worsens heart rate variability, activity and heart rate, as shown by a continuous monitoring by implantable biventricular pacemakers in heart failure patients.

Puglisi A, Gasparini M, Lunati M, Sassara M, Padeletti L, Landolina M, Botto GL, Vincenti A, Bianchi S, Denaro A, Grammatico A, Boriani G; InSync III Italian Registry Investigators.

J Cardiovasc Electrophysiol. 2008 Jul;19(7):693-701. doi: 10.1111/j.1540-8167.2007.01093.x. Epub 2008 Mar 4.

PMID:
18328039

Supplemental Content

Loading ...
Support Center